Your SlideShare is downloading. ×
6. aminoglycosides
Upcoming SlideShare
Loading in...5
×

Thanks for flagging this SlideShare!

Oops! An error has occurred.

×
Saving this for later? Get the SlideShare app to save on your phone or tablet. Read anywhere, anytime – even offline.
Text the download link to your phone
Standard text messaging rates apply

6. aminoglycosides

1,694
views

Published on

Published in: Technology, Business

1 Comment
1 Like
Statistics
Notes
No Downloads
Views
Total Views
1,694
On Slideshare
0
From Embeds
0
Number of Embeds
0
Actions
Shares
0
Downloads
101
Comments
1
Likes
1
Embeds 0
No embeds

Report content
Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
No notes for slide

Transcript

  • 1. Aminoglycosides Tetra cyclines Macrolids Chloramphenicol
  • 2.  Structure Glycosidic Aminosugar - O - Aminocyclitol 2-deoxystreptamine - O- Aminosugar Streptomycin Streptidine - O - Strepose aminosugar - O - N-methyl-Lglucosamine aminosugar Streptobiosamine
  • 3. Aminoglycosides Penetrate Bact. Cell Wall To Periplasmic Space Transport Across Cytoplasmic Membrane (Oxygen Dependent) Bind To 30s Ribosomal Units Prevent Formation of ‘Initiation Complex’ Misreading of Genetic Code on mRNA Incorrect Amino Acids into Peptide Chain Inhibits Protein Synthesis
  • 4.  All derived from an actinomycete or are semisynthetic derivatives  Bactericidal  Are  action highly polar compounds GIT poor absorption so IV/IM  More active in alkaline pH
  • 5. • STREPTOMYCIN (1944) • KANAMYCIN (1957 ) • GENTAMICIN (1964) • AMIKACIN • SISOMICIN • NEOMYCIN • NEITILMICIN • FRAMYCETIN • TOBRAMYCIN 1967
  • 6.  Suffix-“Mycin”- Streptomyces  “Micin’-Micromonospora
  • 7.  Half life 1-3hr.  Concentration  Single depended killing daily dose result in higher tissue concentration  Interval 8-12hr
  • 8. 1. Plasmid Mediated Bacterial Transferase Enzymes 2. Deletion of Porin Channels 3. Alteration of Receptor Protein on 30s Ribosomal Unit
  • 9. • Very Poor Oral Bioavailability • Poor Distribution • Do Not Cross BBB • Excreted Through Kidney • Excretion is directly proportion to creatine clearence
  • 10. • AEROBIC G-ve BACILLI • ENTEROBACTERIACEAE • NOT EFFECTIVE AGAINST : G +ve BACILLI G –ve COCCI ANAEROBES
  • 11. OTOTOXICITY:AG causes impairment of 8th cranial nerve., accumulate in the endolymph and perilymph of the inner ear leading to vestibular and cochlear damage. • Irrversible NEUROMUSCULAR BLOCKADE
  • 12. NEPHROTOXICITY Inhibition of intracellular Phospholipase A2 in renal brush border Leads to lysosomal distension ,rapture Release acid hydrolases & AG Free drug binds to other cellular organelles Leading to degeneration and necrosis
  • 13.  Spectrum : Y. Pestis, Brucella, F.Tularensis, M.Tuberculosis   TOXICITY : Vestibular > Auditory Lowest Nephrotoxicity USES : • • • • Tuberculosis SABE Plague Tularemia & Brucellosis
  • 14.    Spectrum : Pseudomonas, Proteus, E. Coli, Klebsiella, Enterobacteria & Seretia. TOXICITY : More Nephrotoxic USES : • Respiratory Infection in Critically Ill Pt. • Pelvic Infection • SABE • UTIs • Pseudomonal Infections • Infected Wounds, Burns, & Conjunctivitis
  • 15.  Clinically & PK similar to Gentamicin  Susceptible to Aminoglycoside Inactivating Enzymes  Used Interchangeably with Gentamicin
  • 16.  Semi synthetic Derivative of SISOMYCIN  Resistant to Inactivating Enzymes  Lesser Ototoxicity  Used in Gentamicin Resistant Infections
  • 17.  Identical To Gentamicin  2-4 times More Active Against Pseudomonas & Proteus  Ototoxicity & Nephrotoxicity < Gentamicin  Reserve Alternative to ‘G’
  • 18.  RESISTANT TO BACTERIAL ENZYMES  USED against Gentamicin & Tobramycin Resistant Infections  USES: • Multi drug Resistant TB • Hospital Acquired Infections  Hearing loss > Vestibular loss
  • 19.  HIGHLY TOXIC  UESE • Infected Wounds, Ulcers, Burn • External Ear & Eye Infections • Preoperative Intestinal Antiseptic • Hepatic Coma